Search results
Results From The WOW.Com Content Network
DPMS doubled its revenue between 2004–2007 and employed 65 people in 2008. [1] Freedom Group purchased DPMS Panther Arms on December 14, 2007, the same year it purchased Marlin Firearms. Freedom Group was a consortium of firearms manufacturers and was part of Cerberus Capital Management, a New York private equity investment firm.
The design has been used on many AR-10 derivatives (generally referred to as AR-308 style rifles), for instance in the Knight's Armament SR-25 and DPMS Panther LR-308, as well as bolt-action rifles such as the Mossberg MVP .308, Ruger Precision Rifle and Q FIX. Aftermarket magazines are produced by Magpul, Lancer Systems, and others. [1]
Any rifle which is chambered for 7.62×51mm NATO or .308 Winchester can be converted with only the addition of an appropriate barrel to the .260 Remington. Companies such as Lewis Machine & Tool (LMT), ArmaLite, LaRue, and DPMS Panther Arms are among several companies which currently manufacture tactical rifles for use with this cartridge. [1]
Reports from Fox News and USA TODAY have said that a West Columbia-based firearms manufacturer made the gun used in the shooting of former President Donald Trump.
375 Stalker, Standard military 7.62x51 cases (also .308), length is trimmed, shoulder is reformed, neck is expanded to .375 375 SOCOM, Proprietary. The case head and rim dimensions exactly match the military 7.62x51 (also .308), however, the case body is slightly wider and has more taper. 400 AR, Wildcat. The parent is the 7.35×51mm Carcano ...
The BAR-10 was meant to compete in the .308 market against ArmaLite's AR-10 series rifles and Springfield Armory's M1A Rifle by offering a .308 rifle that could accept the relatively inexpensive metric and inch pattern FN FAL magazines. In 2005 Bushmaster discontinued the BAR-10 line of rifles. [citation needed]
PALERMO — One of the two kindergarteners injured in a Northern California school shooting in early December may not regain the use of his legs, the family told CBS Sacramento on Thursday.
A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...